Cardiff Oncology
CRDF
CRDF
60 hedge funds and large institutions have $10.7M invested in Cardiff Oncology in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 9 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
36% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 14
93% less call options, than puts
Call options by funds: $5K | Put options by funds: $75K
Holders
60
Holding in Top 10
–
Calls
$5K
Puts
$75K
Top Buyers
| 1 | +$328K | |
| 2 | +$138K | |
| 3 | +$96.5K | |
| 4 |
Two Sigma Investments
New York
|
+$32.6K |
| 5 |
CC
Callan Capital
La Jolla,
California
|
+$19K |
Top Sellers
| 1 | -$272K | |
| 2 | -$134K | |
| 3 | -$82.6K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$59.1K |
| 5 |
CL
CSS LLC
Chicago,
Illinois
|
-$55K |